Revvity Inc. (NYSE:RVTY – Get Free Report) announced a quarterly dividend on Thursday, April 30th. Stockholders of record on Friday, July 17th will be paid a dividend of 0.07 per share on Friday, August 7th. This represents a c) dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Friday, July 17th.
Revvity has a dividend payout ratio of 5.1% indicating that its dividend is sufficiently covered by earnings. Analysts expect Revvity to earn $5.99 per share next year, which means the company should continue to be able to cover its $0.28 annual dividend with an expected future payout ratio of 4.7%.
Revvity Stock Up 0.2%
Shares of Revvity stock opened at $86.76 on Friday. The company has a market cap of $9.70 billion, a price-to-earnings ratio of 41.71, a price-to-earnings-growth ratio of 1.84 and a beta of 1.05. The company’s 50 day moving average is $90.39 and its 200 day moving average is $96.74. Revvity has a twelve month low of $81.22 and a twelve month high of $118.30. The company has a quick ratio of 1.40, a current ratio of 1.68 and a debt-to-equity ratio of 0.36.
Institutional Trading of Revvity
A number of hedge funds and other institutional investors have recently bought and sold shares of RVTY. EdgePoint Investment Group Inc. grew its stake in shares of Revvity by 26.3% during the 3rd quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company’s stock valued at $751,536,000 after acquiring an additional 1,784,620 shares during the period. Allspring Global Investments Holdings LLC raised its stake in Revvity by 127.0% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock worth $171,921,000 after acquiring an additional 980,142 shares during the period. Norges Bank bought a new stake in Revvity during the 4th quarter worth approximately $80,382,000. Morgan Stanley lifted its holdings in Revvity by 29.6% during the fourth quarter. Morgan Stanley now owns 2,844,464 shares of the company’s stock valued at $275,202,000 after purchasing an additional 650,083 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Revvity by 39.0% in the third quarter. Dimensional Fund Advisors LP now owns 2,125,957 shares of the company’s stock worth $186,307,000 after purchasing an additional 596,436 shares during the period. Hedge funds and other institutional investors own 86.65% of the company’s stock.
About Revvity
Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.
Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.
Further Reading
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.
